受强制性开放获取政策约束的文章 - Rafik Karaman了解详情
无法在其他位置公开访问的文章：5 篇
Comparing Class A GPCRs to bitter taste receptors: Structural motifs, ligand interactions and agonist-to-antagonist ratios
A Di Pizio, A Levit, M Slutzki, M Behrens, R Karaman, MY Niv
Methods in cell biology 132, 401-427, 2016
强制性开放获取政策： German Research Foundation
The future of prodrugs–design by quantum mechanics methods
R Karaman, B Fattash, A Qtait
Expert opinion on drug delivery 10 (5), 713-729, 2013
强制性开放获取政策： German Research Foundation
Probing the binding pocket of the broadly tuned human bitter taste receptor TAS2R14 by chemical modification of cognate agonists
R Karaman, S Nowak, A Di Pizio, H Kitaneh, A Abu‐Jaish, W Meyerhof, ...
Chemical biology & drug design 88 (1), 66-75, 2016
强制性开放获取政策： German Research Foundation, European Commission
A singularity model for chemical reactivity
FM Menger, R Karaman
Chemistry–A European Journal 16 (5), 1420-1427, 2010
强制性开放获取政策： US National Institutes of Health
Computationally-designed phenylephrine prodrugs–a model for enhancing bioavailability
R Karaman, D Karaman, I Zeiadeh
Molecular Physics 111 (21), 3249-3264, 2013
强制性开放获取政策： German Research Foundation
可在其他位置公开访问的文章：21 篇
Prodrugs Design Based on Inter‐and Intramolecular Chemical Processes
R Karaman
Chemical biology & drug design 82 (6), 643-668, 2013
强制性开放获取政策： German Research Foundation
Prodrugs for masking bitter taste of antibacterial drugs—a computational approach
R Karaman
Journal of molecular modeling 19, 2399-2412, 2013
强制性开放获取政策： German Research Foundation
Design, synthesis and in vitro kinetic study of tranexamic acid prodrugs for the treatment of bleeding conditions
R Karaman, H Ghareeb, KK Dajani, L Scrano, H Hallak, S Abu-Lafi, ...
Journal of computer-aided molecular design 27, 615-635, 2013
强制性开放获取政策： German Research Foundation
Computationally Designed Prodrugs for Masking the Bitter Taste of Drugs
R Karaman
Drug Designing:Open Access 1 (2), 1-3, 2012
强制性开放获取政策： German Research Foundation
Computationally designed prodrugs of statins based on Kirby’s enzyme model
R Karaman, W Amly, L Scrano, G Mecca, SA Bufo
Journal of molecular modeling 19, 3969-3982, 2013
强制性开放获取政策： German Research Foundation
Prodrug Design by Computation Methods: A New Era
R Karaman
Drug Designing Open Access 2 (1), 1-5, 2013
强制性开放获取政策： German Research Foundation
Computationally Designed Enzyme Models to Replace Natural Enzymes in Prodrug Approaches
R Karaman
Drug Designing Open Access 1 (3), 1-3, 2012
强制性开放获取政策： German Research Foundation
From Conventional Prodrugs to Prodrugs Designed By Molecular Orbital Methods
R Karaman
Frontiers in Computational Chemistry 1, 3-66, 2014
强制性开放获取政策： German Research Foundation
Computationally Designed Atovaquone Prodrugs Based on Bruice’s Enzyme Model
R Karaman, B Fattash, G Mecca, M Bader
Current computer-aided drug design 10 (1), 15-27, 2014
强制性开放获取政策： German Research Foundation
Design, Synthesis, and In Vitro Kinetics Study of Atenolol Prodrugs for the Use in Aqueous Formulations
R Karaman, A Qtait, KK Dajani, S Abu Lafi
The Scientific World Journal 2014 (1), 248651, 2014
强制性开放获取政策： German Research Foundation
Prodrug Design vs. Drug Design
R Karaman
Drug Designing: open access 2 (2), 1-4, 2013
强制性开放获取政策： German Research Foundation
ANTIMALARIAL ATOVAQUONE PRODRUGS BASED ON ENZYME MODELS - MOLECULAR ORBITAL CALCULATIONS APPROACH
R Karaman
Antimalariak Drug Research and Development 1, 1-68, 2013
强制性开放获取政策： German Research Foundation
The Prodrug Naming Dilemma
R Karaman
Drug Designing Open Access 2 (2), 1-4, 2013
强制性开放获取政策： German Research Foundation
A Solution to Aversive Tasting Drugs for Pediatric and Geriatric Patients
R Karaman
Drug Des 2, e116, 2013
强制性开放获取政策： German Research Foundation
Proton shuffling in acid/base‐catalyzed enolizations: a computational study
R Karaman, FM Menger
Journal of Physical Organic Chemistry 25 (12), 1336-1342, 2012
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定